Olumiant Patient and HCP Website Feb 25, 2019Feb 28, 2019 Brand: Olumiant (baricitinib), Tablets Parent Company: Eli Lilly Drug Type: Prescription Drug Category: Rheumatology Campaign: Launch, Post-Launch Targeting: HCPs, Patients, Caregivers Patient Website: https://www.olumiant.com/ HCP Website: https://www.olumiant.com/hcp/ Homepage (Patient) What Is Olumiant Mobile (Patient) HCP Menu MOA (HCP) Clinical Trial (HCP) Ask Lilly